加味生脉散联合铺灸法治疗慢性持续期肥胖型哮喘临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R562.25

基金项目:

浙江省中医药科学研究基金项目(A类)(2020ZA106)


Clinical Study on Modified Shengmai San Combined with Long-Snake Moxibustion for Chronic Persistent Asthma with Obesity
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察加味生脉散联合铺灸法治疗慢性持续期肥胖型哮喘的临床疗效。方法:选取90例肥胖 型哮喘患者,根据随机数字表法分为A、B、C 3组各30例。A组予加味生脉散治疗,B组予药物铺灸法治疗, C组予加味生脉散联合药物铺灸法联合治疗,连续治疗4周。比较3组治疗前后中医证候评分、哮喘控制测 试(ACT) 评分、肺功能指标[最大呼气流速(PEF)、用力肺活量(FVC)、第1秒用力呼气容积(FEV1) / FVC]、血清学指标[白细胞介素-6 (IL-6)、白细胞介素-18 (IL-18)、干扰素-γ (INF-γ)、免疫球蛋白 E (IgE)、脂联素、瘦素],并比较3组不良反应发生情况。结果:治疗后,3组中医证候评分均降低(P< 0.05),且C组低于A组、B组(P<0.05);3组ACT评分均升高(P<0.05),C组高于A组、B组(P<0.05); A、B 2组中医证候评分、ACT评分比较,差异均无统计学意义(P>0.05)。治疗后,3组FVC、FEV1/FVC、 PEF 均升高(P<0.05),且C 组均高于A 组、B 组(P<0.05);A、B 2 组比较,差异均无统计学意义(P> 0.05)。治疗后,3组血清IL-6、IL-18、IgE、瘦素均降低(P<0.05),且C组低于A组、B组(P<0.05);3组 脂联素、INF-γ均升高(P<0.05),且C组高于A组、B组(P<0.05);A、B 2组上述血清指标比较,差异均 无统计学意义(P>0.05)。3组均未发生严重不良反应。结论:加味生脉散联合铺灸法治疗慢性持续期肥胖型 哮喘患者,可改善哮喘情况,减轻临床症状,改善肺功能,其作用机制可能与调控细胞因子和炎性因子水平、 降低炎症反应、改善中医体质有关。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Shengmai San combined with longsnake moxibustion for chronic persistent asthma with obesity. Methods:A total of 90 cases of patients with asthma with obesity were selected and divided into group A, B, and C according to the random number table method, with 30 cases in each group. group A was treated with modified Shengmai San, group B with medicinal long-snake moxibustion, and group C with modified Shengmai San and long-snake moxibustion. All groups were continuously treated for four weeks. Traditional Chinese medicine syndrome scores,Asthma Control Test (ACT) scores,lung function indicator [peak expiratory flow (PEF),forced vital capacity (FVC), and forced expiratory volume in the first second (FEV1)/FVC], serological indicators [interleukin-6 (IL-6),interleukin-18 (IL-18),interferon-γ (INF-γ),immunoglobulin E (IgE),adiponectin, and leptin] were compared among the three groups before and after treatment; adverse reactions were compared among the three groups. Results: After treatment, traditional Chinese medicine syndrome scores in the three groups were declined (P<0.05), and the scores in group C were lower than those in groups A and B (P<0.05); ACT scores in the three groups were increased (P<0.05), and the scores in group C were higher than those in group A and B (P<0.05);there was no significant difference being found between group A and B (P>0.05). After treatment, FVC, FEV1/FVC, and PEF in the three groups were improved (P<0.05),and the above indicators in group C were higher than those in group A and B (P<0.05); there was no significant difference being found between group A and B (P>0.05). After treatment,IL-6, IL-18,IgE,and leptin in serum in the three groups were decreased (P<0.05),and the above indicators in group C were lower than those in group A and B (P<0.05); adiponectin, and INF- γ in the three groups were increased (P<0.05),and the above indicators in group C were higher than those in group A and B (P< 0.05);there was no significant difference being found between group A and B (P>0.05). No severe adverse reactions happened in the three groups. Conclusion:Modified Shengmai San and long-snake moxibustion for chronic persistent asthma with obesity can improve asthma,alleviate clinical symptoms,and enhance lung function. Its mechanism of action may be related to regulating the levels of cytokines and inflammatory factors,reducing inflammatory responses,and improving Chinese medicine constitution.

    参考文献
    相似文献
    引证文献
引用本文

李斌武,马彦俏,冯卿.加味生脉散联合铺灸法治疗慢性持续期肥胖型哮喘临床研究[J].新中医,2024,56(15):19-23

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-08-11
  • 出版日期:
文章二维码